Brief: 2cureX: Inditreat Selected To Multinational Ovarian Cancer Project
Feb 4 (Reuters) - 2cureX AB 2CUREX.ST :
* INDITREAT® SELECTED TO PRESTIGIOUS MULTINATIONAL OVARIAN
CANCER
PROJECT.
* 2CUREX WILL PROVIDE FUNCTIONAL PRECISION TESTING WITHIN A
PRESTIGIOUS MULTINATIONAL OVARIAN CANCER PROJECT, DECIDER, WHICH
HAS BEEN GRANTED 15 MEUR FROM EU
Source text for Eikon: ID:nWkr2Yr5qf
Further company coverage: 2CUREX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))